Suresh Pathak
About Suresh Pathak
Suresh Pathak has 21 years in corporate governance. Holds Director and Nominee Director roles. Currently with 2 companies, including Giovell Health Care India Private Limited and Herbogene Lifesciences Private Limited. Formerly with 2 companies, such as Gls Pharma Limited and Vannsh Life Sciences Private Limited. Engaged in Healthcare, General Business.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Giovell Health Care India Private Limited
U85191DL2007PTC170327
|
Director | 12 Nov 2007 | 2007 | Active |
Herbogene Lifesciences Private Limited
U74999UP2018PTC102265
|
Nominee Director | 21 Oct 2024 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Gls Pharma Limited
U24239TS2004PLC184306
|
Director | 01 Sep 2004 | 2004 | Active |
Vannsh Life Sciences Private Limited
U24100TG2014PTC094869
|
Additional Director | 04 Oct 2014 | 2014 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suresh Pathak
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suresh Pathak
Suresh Pathak has 21 years in corporate governance. Holds Director and Nominee Director roles. Currently with 2 companies, including Giovell Health Care India Private Limited and Herbogene Lifesciences Private Limited. Formerly with 2 companies, such as Gls Pharma Limited and Vannsh Life Sciences Private Limited. Engaged in Healthcare, General Business.
Suresh Pathak is associated with 2 companies as Director and Nominee Director.
Suresh Pathak has expertise in Healthcare, General Business.
Suresh Pathak has 21 years in corporate governance.